Consensus AstraZeneca PLC Deutsche Boerse AG

Equities

ZEG

GB0009895292

Real-time Estimate Tradegate Other stock markets 09:01:27 2024-07-16 EDT			5-day change	1st Jan Change
143.4 ^EUR	-0.45%		+0.81%	+17.36%

07-15	Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast...
07-15	AstraZeneca: acquisition of Amolyt Pharma finalized	CF

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

2f72a0d71efb4fb54db128ed97c7d.3Aq-ynGuL2EubrhXx7At47pcQ_MBssdeJBurKtlnBss.kyf3vzvLYFJLNtNitNtKktgVDplm-Lc0SU7DUpIvPoi6RYypGs94OGQh3w~45faa5e7e785335dbe657b5c375cab54

Analyst Recommendations on AstraZeneca PLC

ASTRAZENECA : Deutsche Bank reiterates its Neutral rating	07-10	ZD
Barclays raises Kerry, cuts Hunting, Wood Group	07-10	AN
ASTRAZENECA : JP Morgan reaffirms its Buy rating	07-10	ZD
ASTRAZENECA : Goldman Sachs maintains a Buy rating	07-04	ZD
ASTRAZENECA : Buy rating from Berenberg	07-03	ZD
ASTRAZENECA : Jefferies reaffirms its Neutral rating	07-02	ZD
Deutsche Bank cuts Quilter, ups Polar Capital	07-02	AN
AstraZeneca: CHMP recommends Imfinzi and Lynparza	07-01	CF
ASTRAZENECA : Deutsche Bank sticks Neutral	06-26	ZD
ASTRAZENECA : Goldman Sachs reiterates its Buy rating	06-25	ZD
ASTRAZENECA : Barclays maintains a Buy rating	06-24	ZD
ASTRAZENECA : Goldman Sachs maintains a Buy rating	06-18	ZD
Global markets live: AstraZeneca, Apple, Meta, Microsoft, Cisco...	06-17
ASTRAZENECA : Berenberg raises its price target	06-10	CF
AstraZeneca shares outperform, Berenberg raises target	06-10	CF
Berenberg Raises AstraZeneca PT, Maintains Buy Rating	06-10	MT
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating	06-10	MT
JPMorgan cuts Aviva but lifts M&G	06-10	AN
ASTRAZENECA : Berenberg gives a Buy rating	06-10	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	06-07	ZD
HSBC Raises AstraZeneca PT, Keeps Buy Rating	06-05	MT
ASTRAZENECA : Deutsche Bank remains Neutral	06-05	ZD
ASTRAZENECA : Goldman Sachs reiterates its Buy rating	06-05	ZD
Berenberg raises Taylor Wimpey to 'buy'	06-05	AN
ASTRAZENECA : UBS reiterates advice after ASCO meeting	06-04	CF

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

157.2 USD

Average target price

177.6 USD

Spread / Average Target

+13.00%

High Price Target

225.8 USD

Spread / Highest target

+43.68%

Low Price Target

140.6 USD

Spread / Lowest Target

-10.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JPMORGAN	James Gordon
GOLDMAN SACHS	Rajan Sharma
BERENBERG	Luisa Hector
JEFFERIES	Peter Welford
BARCLAYS	Emily Field
Berenberg Bank
HSBC
UBS	Matthew Weston
Stifel Nicolaus
Jefferies & Co.
DZ BANK	Elmar Kraus
alphavalue	Abhishek Raval
BERNSTEIN RESEARCH	Justin Smith
Deutsche Bank Securities
Bernstein
RBC Capital Markets
B. Riley
BMO Capital
CREDIT SUISSE	Dominic Lunn
Argus
Morgan Stanley
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK	Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA)	Sachin Jain

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar